SHIKONIN, ALKANNIN; AND RACEMIC PARENT NUCLEUS CABONYL OXIME DERIVATIVES AND APPLICATIONS THEREOF
申请人:SHANGHAI JIAO TONG UNIVERSITY
公开号:US20150344415A1
公开(公告)日:2015-12-03
A structural formula of a shikonin naphthazarin parent nucleus hydroxyl methylation carbonyl oxime derivative is shown in Formula (I) or (II); a structural formula of an alkannin naphthazarin parent nucleus hydroxyl methylation carbonyl oxime derivative is shown in Formula (III) or (IV); and a structural formula of a racemic shikonin naphthazarin parent nucleus hydroxyl methylation carbonyl oxime derivative is shown in Formula (V) or (VI), wherein R1 is alkane, olefin, arene, or substituting arene comprising 1 to 6 carbon atoms; and R2 is alkane, olefin, arene, or substituting arene comprising 1 to 6 carbon atoms or is H. The shikonin, alkannin, and racemic oxime derivatives of the present invention have novel structures, and in-vitro experiments show that the present invention has good growth inhibitory activity against tumor cells and can be used in tumor treatment.
该申请的新颖结构的芪酮、茜草酮和消旋肟衍生物的结构式如下:芪酮萘酚基亚甲基羟甲基羰基肟衍生物的结构式为(I)或(II);茜草酮萘酚基亚甲基羟甲基羰基肟衍生物的结构式为(III)或(IV);消旋芪酮萘酚基亚甲基羟甲基羰基肟衍生物的结构式为(V)或(VI),其中R1是烷烃、烯烃、芳烃或含有1至6个碳原子的取代芳烃;R2是烷烃、烯烃、芳烃或含有1至6个碳原子的取代芳烃,或者是氢。该发明的芪酮、茜草酮和消旋肟衍生物具有新颖的结构,在体外实验中显示出对肿瘤细胞有良好的生长抑制活性,并可用于肿瘤治疗。